Description
Semacyl® is a sterile solution containing semaglutide, a synthetic glucagon-like peptide-1 analogue. The molecule incorporates structural modifications, including amino acid substitution and fatty acid side-chain attachment, which distinguish it from the native peptide sequence and support its suitability as a modified peptide active substance.
The aqueous solution is suited to a peptide compound intended for subcutaneous injection. In this dosage form, semaglutide is maintained in dissolved form within a sterile water-based vehicle, where the preparation is centred on peptide solubility rather than oil-depot release, ester hydrolysis or crystalline-particle dissolution.
Further details on composition, method of use, precautions, possible side effects, contraindications and storage are provided in the package leaflet.